US Stock MarketDetailed Quotes

PHVS Pharvaris

Watchlist
  • 18.500
  • +0.010+0.05%
Close Dec 18 16:00 ET
1.00BMarket Cap-6.87P/E (TTM)

About Pharvaris Company

Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.

Company Profile

SymbolPHVS
Company NamePharvaris
Listing DateFeb 5, 2021
Issue Price20.00
Founded2015
CEOMr. Berndt Modig
MarketNASDAQ
Employees82
Fiscal Year Ends12-31
AddressEmmy Noetherweg 2
CityLeiden
ProvinceZuid-Holland
CountryNetherlands (the)
Zip Code2333 BK
Phone31-71-203-64-10

Company Executives

  • Name
  • Position
  • Salary
  • Berndt Modig
  • Chief Executive Officer and Executive Director
  • 935.28K
  • Dr. Wim Souverijns, PhD
  • Chief Community Engagement and Commercial Officer
  • --
  • Joan Schmidt
  • Chief Legal Officer
  • --
  • Dr. Peng Lu, M.D.,PhD
  • Chief Medical Officer
  • --
  • Dr. Morgan Conn, PhD
  • Chief Business Officer
  • --
  • Dr. Anne Lesage, PhD
  • Chief Early Development Officer
  • --
  • Annick Deschoolmeester
  • Chief Human Resources Officer
  • --
  • Dr. Stefan Abele, PhD
  • Chief Technical Operations Officer
  • --
  • Anna Nijdam, M.Sc.
  • Head of Strategic Finance and Principal Accounting Officer
  • --
  • Dr. Robert Glassman, M.D.
  • Independent Director
  • 50.50K
  • Viviane Monges
  • Independent Director
  • 62.50K
  • Dr. Elisabeth Bjork, M.D.,PhD
  • Independent Director
  • 45.00K
  • Hans Schikan, Pharm.D.
  • Independent Director
  • 61.00K
  • Dr. David P. Meeker,M.D.
  • Independent Director
  • 94.00K
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.